# SafeTrack åŒ»å­¦æ–‡çŒ®æ”¯æ’‘ä¸é˜ˆå€¼è¯æ˜

## ğŸ¥ æ ¸å¿ƒå¥åº·é˜ˆå€¼çš„åŒ»å­¦ä¾æ®

### 1. å¿ƒç‡æ ‡å‡† (Heart Rate Thresholds)

#### åŸºç¡€æ ‡å‡†
- **American Heart Association (2023)**: æˆäººé™æ¯å¿ƒç‡ 60-100 bpm
- **European Society of Cardiology Guidelines**: è¿åŠ¨æ—¶æœ€å¤§å¿ƒç‡ = 220 - å¹´é¾„

#### å¹´é¾„ç›¸å…³è°ƒæ•´çš„åŒ»å­¦ä¾æ®
```typescript
// å½“å‰å®ç°çš„å¹´é¾„è°ƒæ•´
if (age >= 65) {
  heartRateMax = 130;  // è€å¹´äººæœ€å¤§å¿ƒç‡é™ä½
} else if (age < 25) {
  heartRateMax = 160;  // å¹´è½»äººå¯æ‰¿å—æ›´é«˜å¿ƒç‡
}
```

**åŒ»å­¦æ”¯æ’‘**:
- **Tanaka, H. et al. (2001)** - "Age-predicted maximal heart rate revisited" 
  - å…¬å¼: HRmax = 208 - (0.7 Ã— age)
  - è¯æ˜äº†éšå¹´é¾„å¢é•¿å¿ƒç‡ä¸Šé™çš„ç”Ÿç†æ€§ä¸‹é™

- **Nes, B.M. et al. (2013)** - "Age-predicted maximal heart rate in healthy subjects"
  - å‘ç°ä¼ ç»Ÿ220-ageå…¬å¼ä½ä¼°äº†å¹´è½»äººçš„å¿ƒç‡ä¸Šé™
  - æ”¯æŒå¹´è½»äºº(<25å²)æ›´é«˜å¿ƒç‡é˜ˆå€¼çš„è®¾å®š

### 2. è¡€å‹æ ‡å‡† (Blood Pressure Thresholds)

#### åŸºç¡€æ ‡å‡†
- **AHA/ACC 2017 Guidelines**: 
  - æ­£å¸¸: <120/80 mmHg
  - åé«˜: 120-129/<80 mmHg  
  - Stage 1é«˜è¡€å‹: 130-139/80-89 mmHg

#### å½“å‰å®ç°çš„é˜ˆå€¼
```typescript
// SafeTracké»˜è®¤é˜ˆå€¼
systolicMin = 90, systolicMax = 140;
diastolicMin = 60, diastolicMax = 90;
```

**åŒ»å­¦æ”¯æ’‘éœ€è¦è¡¥å……**:
- [ ] **æ€¥éœ€æ·»åŠ **: Williams, B. et al. (2018) - "2018 ESC/ESH Guidelines for hypertension"
- [ ] **æ€¥éœ€æ·»åŠ **: Whelton, P.K. et al. (2018) - "2017 AHA/ACC guideline for high blood pressure"

### 3. æ€§åˆ«å·®å¼‚è°ƒæ•´çš„åŒ»å­¦ä¾æ®

#### å½“å‰å®ç°
```typescript
if (gender === 'female') {
  heartRateMin = 65;   // å¥³æ€§å¿ƒç‡é€šå¸¸ç•¥é«˜
  systolicMax -= 5;    // å¥³æ€§è¡€å‹é€šå¸¸ç•¥ä½
}
```

**åŒ»å­¦æ”¯æ’‘**:
- **Vaidya, A. & Forman, J.P. (2018)** - "Hypertension in women"
  - è¯æ˜ç»ç»å‰å¥³æ€§è¡€å‹é€šå¸¸ä½äºåŒé¾„ç”·æ€§
  - æ”¯æŒå¥³æ€§è¡€å‹é˜ˆå€¼é€‚å½“é™ä½çš„è®¾å®š

- **Koenig, J. & Thayer, J.F. (2016)** - "Sex differences in healthy human heart rate variability"
  - å¥³æ€§é™æ¯å¿ƒç‡å¹³å‡æ¯”ç”·æ€§é«˜5-10 bpm
  - æ”¯æŒå¥³æ€§å¿ƒç‡åŸºçº¿è°ƒæ•´

### 4. ç–¾ç—…çŠ¶å†µè°ƒæ•´

#### é«˜è¡€å‹æ‚£è€…è°ƒæ•´
```typescript
if (conditions.includes('hypertension')) {
  if (systolicThreshold) systolicThreshold.maxValue = Math.min(systolicThreshold.maxValue, 130);
  if (diastolicThreshold) diastolicThreshold.maxValue = Math.min(diastolicThreshold.maxValue, 80);
}
```

**åŒ»å­¦æ”¯æ’‘**:
- **Target BP levels**: AHAæ¨èé«˜è¡€å‹æ‚£è€…ç›®æ ‡<130/80 mmHg
- **éœ€è¦æ·»åŠ å…·ä½“æ–‡çŒ®å¼•ç”¨**

## âš ï¸ éœ€è¦ç«‹å³è¡¥å……çš„å…³é”®æ–‡çŒ®

### é«˜ä¼˜å…ˆçº§ (è®ºæ–‡å¿…éœ€)
1. **American Heart Association Scientific Statements**
2. **European Society of Cardiology Guidelines 2020**  
3. **WHO Global Health Observatory Data**
4. **Age-stratified cardiovascular risk assessment studies**

### ä¸­ç­‰ä¼˜å…ˆçº§ (å¢å¼ºå¯ä¿¡åº¦)
1. **Mobile health intervention effectiveness studies**
2. **Personalized medicine in cardiovascular care**
3. **Digital health monitoring accuracy research**

## ğŸ¯ æ–‡çŒ®æœç´¢ç­–ç•¥

### æ•°æ®åº“æœç´¢
- **PubMed**: å¿ƒè¡€ç®¡ç”Ÿç†å­¦åŸºç¡€ç ”ç©¶
- **Cochrane Library**: ç³»ç»Ÿç»¼è¿°å’Œmetaåˆ†æ
- **IEEE Xplore**: ç§»åŠ¨å¥åº·æŠ€æœ¯ç ”ç©¶
- **Google Scholar**: æœ€æ–°é¢„å°æœ¬å’Œç»¼åˆæœç´¢

### å…³é”®è¯ç»„åˆ
```
("heart rate" OR "blood pressure") AND 
("age" OR "gender" OR "sex differences") AND
("thresholds" OR "normal ranges" OR "reference values") AND
("mobile health" OR "mHealth" OR "digital health")
```

## ğŸ“Š å½“å‰é˜ˆå€¼éªŒè¯çŠ¶æ€

| å¥åº·æŒ‡æ ‡ | å½“å‰é˜ˆå€¼ | åŒ»å­¦ä¾æ®çŠ¶æ€ | éœ€è¦çš„æ–‡çŒ® |
|---------|---------|-------------|-----------|
| å¿ƒç‡ | 60-150 bpm | âš ï¸ éƒ¨åˆ†æ”¯æ’‘ | AHA guidelines |
| æ”¶ç¼©å‹ | 90-140 mmHg | âŒ ç¼ºä¹å¼•ç”¨ | 2017 ACC/AHA |
| èˆ’å¼ å‹ | 60-90 mmHg | âŒ ç¼ºä¹å¼•ç”¨ | ESC guidelines |
| å¹´é¾„è°ƒæ•´ | 65+: ä¿å®ˆ | âœ… æœ‰æ–‡çŒ® | Tanaka 2001 |
| æ€§åˆ«è°ƒæ•´ | å¥³æ€§+5å¿ƒç‡ | âš ï¸ éœ€è¡¥å…… | Koenig 2016 |

## ğŸš¨ ç«‹å³è¡ŒåŠ¨é¡¹

1. **ä»Šæ—¥å®Œæˆ**: æœç´¢å¹¶ä¸‹è½½5ç¯‡æ ¸å¿ƒåŒ»å­¦æŒ‡å—
2. **æ˜æ—¥å®Œæˆ**: éªŒè¯æ‰€æœ‰æ•°å€¼çš„åŒ»å­¦å‡†ç¡®æ€§  
3. **48å°æ—¶å†…**: æ›´æ–°AlertEngine.tsä¸­çš„æ³¨é‡Šï¼Œæ·»åŠ æ–‡çŒ®å¼•ç”¨